{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:41:53Z","timestamp":1785807713243,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.parkreldis.2005.05.011","type":"journal-article","created":{"date-parts":[[2005,9,24]],"date-time":"2005-09-24T11:10:13Z","timestamp":1127560213000},"page":"413-420","source":"Crossref","is-referenced-by-count":52,"title":["Nicotinamide: A double edged sword"],"prefix":"10.1016","volume":"11","author":[{"given":"Adrian","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2005.05.011_bib1","series-title":"The butterfly caste. A social history of pellagra in the South","author":"Etheridge","year":"1972"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib2","doi-asserted-by":"crossref","unstructured":"Goldberger J, Wheeler GA, Sydenestricker E. Pellagra incidence in relation to sex, age, season, occupation, and disabling sickness in seven Cotton-Mill Villages of South Carolina during 1916. Public Health Reports 1920;35:1663.","DOI":"10.2307\/4575643"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib3","doi-asserted-by":"crossref","unstructured":"Goldberger J, Waring CH, Willets DG. The treatment and prevention of pellagra. Public Health Reports 1914;29:2821\u20135.","DOI":"10.2307\/4571457"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/ja01288a509","article-title":"Relation of nicotinic acid and nicotinic acid amide and to canine black tongue","volume":"59","author":"Elvehjem","year":"1937","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib5","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1001\/jama.1937.92780510001008","article-title":"\u2018Pellagra successfully treated with nicotinic acid\u2019","volume":"109","author":"Smith","year":"1993","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.1938.02790090004002","article-title":"\u2018The use of nicotinic acid in the treatment of pellagra\u2019","volume":"110","author":"Spies","year":"1938","journal-title":"JAMA"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib7","first-page":"282","article-title":"Aetiology of pellagra and the nutritive value of maize","author":"Anon.","year":"1938","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib8","series-title":"Report of the conference on the post war loaf. Cmd.6701","year":"1945"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib9","article-title":"Food Standards Committee","author":"Ministry of Agriculture, Fisheries and Food","year":"1974"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0165-6147(03)00078-6","article-title":"Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain","volume":"24","author":"Maise","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.pharmtox.39.1.19","article-title":"Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyl transferase and histamine N-methyl transferase","volume":"39","author":"Weinshilboum","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0003-9861(88)90487-0","article-title":"Substrate specificity of nicotinamide methyl transferase isolated from porcine liver","volume":"260","author":"Alston","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib15","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/0006-2952(86)90436-3","article-title":"Role of N-methyl-transferases in the neurotoxicity associated with the metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and other 4-substituted pyridines in the environment","volume":"35","author":"Ansher","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-8993(92)90576-U","article-title":"Indole-N-methylated \u03b2-carbolinium ions as potential brain - bioactivated neurotoxins","volume":"570","author":"Collins","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","article-title":"Isoquinoline neurotoxins in the brain and Parkinson's disease","volume":"29","author":"Nagatasu","year":"1997","journal-title":"Neurosci Res"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1126\/science.1102497","article-title":"NAD to the Rescue","volume":"305","author":"Bedalov","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1471-4159.2000.0750982.x","article-title":"2-deoxy-d-glusoce prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity","volume":"75","author":"Hervias","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000057762","article-title":"Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endolethial cell injury","volume":"39","author":"Chong","year":"2002","journal-title":"J Vasc Res"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0027-5107(01)00078-1","article-title":"Niacin, poly(ADP-ribose) polymerase-1 and genomic stability","volume":"475","author":"Hageman","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0140-6736(91)90113-4","article-title":"N-methyllation of pyridines in Parkinson's Disease","volume":"338","author":"Green","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s007020070047","article-title":"N-methyllation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test","volume":"107","author":"Akoyama","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(85)90411-2","article-title":"The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking the N-methyl moiety","volume":"61","author":"Bradbury","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1471-4159.1979.tb09919.x","article-title":"Niacin and niacinamide transport in the central nervous system. In vivo studies","volume":"33","author":"Spector","year":"1979","journal-title":"J Neurochem"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/jnen\/61.2.111","article-title":"Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain","volume":"61","author":"Parsons","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1078\/0940-2993-00214","article-title":"Possible role of methylnicotinamide in he pathogenesis of Parkinson's disease","volume":"53","author":"Fukushima","year":"2002","journal-title":"Exp Toxic Pathol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00218-0","article-title":"High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease","volume":"342","author":"Parsons","year":"2003","journal-title":"Neurosci Lett"},{"issue":"suppl 3","key":"10.1016\/j.parkreldis.2005.05.011_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.10479","article-title":"Bioenergetic approaches for neuroprotection in Parkinson's Disease","volume":"53","author":"Beal","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/qjmed\/hci027","article-title":"Parkinson's disease: the first common neurological disease due to auto-intoxication?","volume":"98","author":"Williams","year":"2005","journal-title":"Q J Med"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib31","series-title":"Nutritional disorders of the nervous system. Chap 2. Pellagra","author":"Spillane","year":"1947"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4886(89)90166-0","article-title":"3-Acetyl pyridine-induced degeneration of the nigrostriatal dopamine system: an animal model of olivopontocerebellar atrophy-associated parkinsonism","volume":"105","author":"Deutch","year":"1989","journal-title":"Exp Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02815143","article-title":"Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in Parkinsonism","volume":"26","author":"Charlton","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib34","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/0024-3205(96)00190-7","article-title":"Elevation of cerebrospinal fluid choline levels by nicotinamide involves the enzymatic formation of N-methylnicotinamide in brain tissue","volume":"58","author":"Vargas","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.281.5378.794","article-title":"Choline a vital amine","volume":"281","author":"Blusztajn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib36","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1042\/bst021299s","article-title":"Neurotoxicity of nicotinamide derivatives; their role in the aetiology of Parkinson's disease","volume":"21","author":"Willets","year":"1993","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(03)00350-8","article-title":"Genes and parkinsonism","volume":"2","author":"Hardy","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib38","first-page":"194","article-title":"N-methyllation of pyridines and Parkinson's disease","volume":"60","author":"Williams","year":"1993","journal-title":"Adv Neurol"},{"issue":"10","key":"10.1016\/j.parkreldis.2005.05.011_bib39","first-page":"716","article-title":"The MPTP tale: pathway to prevention of Parkinson's disease?","volume":"49","author":"Williams","year":"1993","journal-title":"Br J Hospital Med"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib40","first-page":"215","article-title":"The aetiology of idiopathic Parkinson's disease: a genetic and environmental model","volume":"80","author":"Williams","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000110318","article-title":"Worldwide occurrence of Parkinson's disease: an updated review","volume":"12","author":"Zhang","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib42","first-page":"960","article-title":"Parkinson's disease in China","volume":"104","author":"Wang","year":"1991","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/archneur.1988.00520360039008","article-title":"Prevalence of Parkinson's disease in the Parsi community of Bombay India","volume":"45","author":"Bharucha","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib44","first-page":"138","article-title":"Morbidity and mortality with Parkinsonism","volume":"24","author":"Williams","year":"1966","journal-title":"J Neurosurg"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib45","first-page":"153","article-title":"Epidemiology of Parkinson's disease","volume":"80","author":"Tanner","year":"1999","journal-title":"Adv Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib46","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1212\/WNL.55.9.1350","article-title":"Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case\u2013control study","volume":"55","author":"Benedetti","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.410390113","article-title":"Dietary lipids and antioxidants in Parkinson's disease. A population based case\u2013control study","volume":"39","author":"Logroscino","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.parkreldis.2004.04.001","article-title":"Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey","volume":"10","author":"Zesiewicz","year":"2004","journal-title":"Parkinsonism Relat Disorders"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.57.3.462","article-title":"Time trends in incidence of Parkinsonism in Olmsted County, Minnesotaa","volume":"57","author":"Rocca","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib50","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.52.2.302","article-title":"Changing epidemiology of Parkinson's disease in southwestern Finland","volume":"52","author":"Kuopio","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib51","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorrell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib52","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archneur.1990.00530070019005","article-title":"Two decades of increasing mortality from Parkinson's Disease amongst the U.S. elderly","volume":"47","author":"Lilienfeld","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib53","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0021-9681(63)90098-5","article-title":"Cohort analysis of Parkinson's syndrome. Evidence for a single etiology related to subclinical infection about 1920","volume":"16","author":"Poskanzer","year":"1963","journal-title":"J Chron Dis"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib54","first-page":"27","article-title":"Paralysis Agitans Mortality in England and Wales, 1855\u20131962","volume":"20","author":"Duvoisin","year":"1966","journal-title":"Br J Prev Soc Med"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archneur.61.6.886","article-title":"Postmenopausal estrogen use affects risk for Parkinson's Disease","volume":"61","author":"Currie","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.47.3.644","article-title":"Diet and Parkinson's disease. II. Possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case\u2013control study","volume":"47","author":"Hellenbrand","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib57","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3181\/00379727-38-9806","article-title":"Toxicity of nicotinic acid","volume":"38","author":"Chen","year":"1938","journal-title":"Prog Soc Exp Biol Med"},{"key":"10.1016\/j.parkreldis.2005.05.011_bib59","series-title":"Epidemiology of neurological and sense organ disorders","first-page":"115","article-title":"Amyotrophic lateral sclerosis and other Motor neurone diseases","author":"Kurland","year":"1973"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380200500163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380200500163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T22:46:39Z","timestamp":1553553999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380200500163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S135380200500163X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2005.05.011","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}